Multimodality Approach to Coronary Ischemic Testing in Pediatric Patients
Published: February 26, 2026
- Provocative and ischemic coronary testing is used in both acquired and congenital heart disease to evaluate the physiologic significance of coronary artery abnormalities by assessing myocardial blood flow and detecting ischemia or vasospasm.
- This scientific statement aims to summarize the current modalities used in pediatric provocative ischemic testing, promote their appropriate application in clinical practice, and guide future technological advancements.
- Understanding the diagnostic performance-including sensitivity, specificity, and implications of test results-is essential for optimal use of these modalities in pediatric care. Ongoing evaluation of their strengths, limitations, and clinical utility will support informed decision-making and innovation in coronary testing.
Multimodality Approach to Coronary Ischemic Testing in Pediatric Patients
Coronary and provocative ischemic testing in children is rapidly advancing. In this brief expert overview, Writing Group Chair Laura Olivieri, MD and Vice Chair Simon Lee, MD introduce the new AHA Scientific Statement on Coronary and Provocative Ischemic Testing in Pediatric Patients—the first statement of its kind. They highlight emerging diagnostic modalities, pediatric specific testing considerations, and key takeaways for congenital and acquired coronary conditions. Perfect for pediatric cardiologists, imagers, and congenital heart disease teams. Watch to learn how this new framework can support safer, more accurate, and more standardized coronary and ischemic testing for children—and why it represents an important step forward for the field.